Wedbush keeps Cerebras at $270 target with 20% upside ahead of Q1

Wedbush maintained its Outperform rating and $270 price target on Cerebras Systems ahead of the company's first quarterly report as a public firm on June 23.

"Demand risk is almost zero given Cerebras's existing deals with OpenAI and Amazon, so results will largely reflect how well management delivers against its own targets," the Wedbush analysts said.

The $270 target implies roughly 20% upside from Cerebras's last close at $224.43. Increased wafer output from TSMC could enable Cerebras to exceed expectations and capture upside in system sales, the analysts said. The upcoming WSE-4 chip launch is expected to boost margins and revenue, though no timing benefit is included in current forecasts.

The report comes as Cerebras prepares to report its first quarterly earnings since its public listing, a key test for the AI chip maker that competes with Nvidia in the fast-growing market for artificial intelligence hardware. A strong print would support the thesis that Cerebras can carve out a meaningful share of the AI chip market beyond Nvidia's dominant position.

Cerebras shares have fallen about 23% from their post-IPO highs as investors weigh the company's valuation against the execution risks inherent in scaling production of its wafer-scale chips. The company relies on TSMC for manufacturing, making foundry capacity a critical variable in its ability to meet demand. The analysts noted that any incremental wafer allocation from TSMC could translate directly into higher system revenue.

The Wedbush view stands as one of the more bullish on the Street. The analysts see the OpenAI and Amazon partnerships as structural demand anchors that reduce the downside risk typically associated with a newly public company's first earnings report. Cerebras's wafer-scale architecture offers a differentiated approach to AI training and inference compared with Nvidia's GPU-based systems, giving it a potential edge in certain workloads.

For holders, the Q1 print will show whether Cerebras can translate its partnership pipeline into financial results that justify its premium valuation. The next event after earnings is the WSE-4 launch timeline, which could drive the next leg of revenue growth and margin expansion.

This article is for informational purposes only and does not constitute investment advice.